The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population

.blurhash-client-img { display: none !important; }

Open Access

|Jul 2016

Figures & Tables

	Age		del5395 Mutation	Frequency (%)	OR	95% CI	p Value
Cancer Groups	Mean	Range
Colorectal	67	18-88	2/568	0.35	0.46	0.04-3.23	0.43
Breast	62	28-89	3/435	0.68	0.90	0.13-5.35	1.00
Ovarian	57	16-86	4/399	1.00	1.32	0.24-7.13	0.73
Prostate	66	42-91	1/419	0.24	0.31	0.06-3.70	0.39
Total	63	16/91	10/1824	0.55	0.75	0.28-1.94	0.52
Control Groups
Healthy donors	35	18-65	4/524	0.76	‒	‒	‒
Chernobyl liquidators	53	33-75	4/480	0.83	1.09	0.20-5.90	1.00
Geriatric patients	73	60-97	3/444	0.68	0.89	0.13-5.28	1.00
Total	53	18-97	11/1450	0.73

Language: English

Page range: 33 - 36

Published on: Jul 9, 2016

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Related subjects:

© 2016 J Plonis, D Kalniete, M Nakazawa-Miklasevica, A Irmejs, E Vjaters, J Gardovskis, E Miklasevics, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.